Negative correlation between plasma fibrinogen and insulin sensitivity measured with the minimal model technique

Clinical Hemorheology and Microcirculation

Volumn 18, Issue 4, 1998, Pages 323-330

  Raynaud, E ^a,b   Brun, J F ^b   Perez Martin, A ^b   Orsetti, A ^b   Solere M ^a  

^a UNIV MONTPELLIER   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

Fibrinogen; Insulin sensitivity; Syndrome X; Theology

Indexed keywords

FIBRINOGEN; INSULIN;

ADULT; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; RISK FACTOR; SYNDROME X;

ADULT; FEMALE; FIBRINOGEN; HEMORHEOLOGY; HUMANS; INSULIN RESISTANCE; MALE; SYNDROME;

EID: 0031849787     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. G.M. Reaven, Role of insulin resistance in human disease, Diabetes 37 (1988), 1595-1607.
2. M.F. Walsh, L.J. Dominguez and J.R. Sowers, Metabolic abnormalities in cardiac ischemia, Cardiol. Clin. 13 (1995), 529-538.
3. R.A. DeFronzo and E. Ferrannini, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care 14 (1991), 173-194.
4. A. Fontbonne, M.A. Charles, N. Thibault, J.L. Richard, J.M. Claude, J.M. Warnet, G.E. Rosselin and E. Eschwege, Hyperinsulinemia as predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15-year follow-up, Diabetologia 34 (1991), 356-361.
5. J.F. Brun, J.F. Monnier, H. Kabbaj and A. Orsetti, La viscosité sanguine est corrélée à l'insulino-résistance, J. Mal. Vasc. 21 (1996), 171-174.
6. E. Ernst and K.L. Resch, Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature, Ann. Intern. Med. 118 (1993), 956-963.
7. A. Hamsten, B. Wiman, U. de Faire and M. Blombäck, Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction, New Engl. J. Med. 313 (1985), 1557-1563.
8. P. Vague, I. Juhan-Vague, M.F. Ailhaud, C. Badier, R. Viard, M.C Alessi and D. Colleen, Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects, Metabolism 35 (1986), 250-253.
9. K. Landin, L. Stigendal, E. Eriksson, M. Krotkievski, B. Risberg, L. Tengborn and U. Smith, Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1, Metabolism 39 (1990), 1044-1048.
10. K. Landin, L. Tengborn and U. Smith, Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease, J. Intern. Med. 227 (1990), 273-278.
11. A. Moan, G. Nordby, I. Os, K.I. Birkeland and S.E. Kjeldsen, Relationship between hemorrheologic factors and insulin sensitivity in healthy young men, Metabolism 43 (1994), 423-427.
12. O. Bouix, J.F. Brun and A. Orsetti, The magnitude, the kinetics and the metabolic efficiency of first-phase insulin response to intravenous glucose are related, Horm. Metabol. Res. 25 (1993), 312-316.
13. G.M. Steil and R.N. Bergman, Reduced sampling for the minimal model estimate of insulin sensitivity from the modified and standard frequently sampled IVGTT, Diabetes 1(Suppl.) (1991), 38A.
14. G.M. Ward. K.M. Weber, I.M. Walters, P.M. Aitken, B. Lee, J.D. Best, R.C. Boston and F.P. Alford, A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes, Metabolism 40 (1991), 4-9.
15. R.N. Bergman, Toward physiological understanding of glucose tolerance. Minimal model approach, Diabetes 38 (1989), 1512-1527.
16. A. Clauss, Gerinnungsphysiologische Schnellmethode zur Bestimmungen des Fibrinogenes, Acta Haematol. 17 (1957), 237-246.
17. J.F. Brun, R. Guintrand-Hugret, C. Boegner, O. Bouix and A. Orsetti, Influence of short submaximal exercise on parameters of glucose assimilation analyzed with the minimal model, Metabolism 44 (1995), 833-840.
18. G. Pacini and R.N. Bergman, MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsitivity from the frequently sampled intravenous glucose tolerance test, Comp. Meth. Prog. Biomed. 23 (1986), 113-122.
19. F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D.I. Chen and G.M. Reaven, Insulin resistance and cigarette smoking, Lancet 339 (1992), 1128-1130.
20. M. Eliasson, K. Asplund, P.E. Evrin and D. Lundblad, Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study, Atherosclerosis 113 (1995), 41-53.
21. R.N. Bergman, L.S. Phillips and C. Cobelli, Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose, J. Clin. Invest. 68 (1981), 1456-1467.
22. S. Welch, S.S.P. Gebhart, R.N. Bergman and L.S. Phillips, Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects, J. Clin. Endocrinol. Metabol. 71 (1990), 1508-1518.
23. R.N. Bergman, R. Prager, A. Volund and J.M. Olefsky, Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp, J. Clin. Invest. 79 (1987), 790-800.
24. A.A. Alzaid, S.F. Dinneen, D.J. Turk, A. Caumo, C. Cobelli and R.A. Rizza, Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans, J. Clin. Invest. 94 (1994), 2341-2348.
25. T.C. Ni, M. Ader and R.N. Bergman, Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis, Diabetes 46 (1997), 1813-1821.
26. P. Bavenholm, A. Proudler, A. Silveira, D. Crook, M. Blombäck, U. de Faire and A. Hamsten, Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease, Thromb. Haemost. 73 (1995), 568-575.
27. S.E. Kahn, R.L. Prigeon, D.K. McCulloch, E.J. Boyko, R.N. Bergman, M.W. Schwartz, J.L. Neifing, K. Ward, J.C. Beard, J.P. Palmer and D.J. Porte, Jr., Quantification of the relationship between insulin sensitivity and β-cell function in human subjects, Diabetes 42 (1993), 1163-1172.
28. J.H. Pinkey, C.D.A. Stehouwer, S.W. Coppack and J.S. Yudkin, Endothelial dysfunction: cause of the insulin resistance syndrome, Diabetes 46(2) (1997), S9-S13.